Contact Us
Drug Search Results
More Filters [+]

Mizolastine

Alternative Names: mizolastine
Latest Update: 2024-03-21
Latest Update Note: News Article

Product Description

Mechanisms of Action: H1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bangladesh | Belgium | Brazil | Chile | Colombia | Egypt | France | Germany | Greece | India | Ireland | Israel | Italy | Korea | Luxembourg | Netherlands | Peru | Portugal | Slovenia | Spain | Sweden | Taiwan | Tunisia | Turkey | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: Xian-Janssen
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Mizolastine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ChiCTR2000037034

N/A

Recruiting

Dermatitis, Atopic

2022-09-30

CTR20201671

N/A

Completed

Urticaria|Rhinitis, Allergic, Seasonal|Rhinitis, Allergic, Perennial

2020-10-13

CR017872

P1

Completed

Healthy Volunteers

2009-06-01

Recent News Events

Date

Type

Title

03/21/2024

News Article

 MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor

08/01/2023

PubMed

 Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

11/24/2021

PubMed

 Formulation and Pathohistological Study of Mizolastine-Solid Lipid Nanoparticles-Loaded Ocular Hydrogels.

12/01/2020

PubMed

 An in-silico evaluation of COVID-19 main protease with clinically approved drugs.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions